Switch theme
Sign up to access all valuation multiples
Shu Yu Civilian Pharmacy Corp Ltd is primarily involved in the operation and sales of Chinese and Western patent medicines, health foods, Chinese herbal medicines, health equipment and other products.
1999
n/a
Last FY Revenue $1.3B
Last FY EBITDA $57.0M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, ShuYu Civilian Pharmacy achieved revenue of $1.3B and an EBITDA of $57.0M.
ShuYu Civilian Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX
See ShuYu Civilian Pharmacy valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.3B | XXX | XXX | XXX |
| Gross Profit | XXX | $339M | XXX | XXX | XXX |
| Gross Margin | XXX | 25% | XXX | XXX | XXX |
| EBITDA | XXX | $57.0M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 4% | XXX | XXX | XXX |
| EBIT | XXX | $3.4M | XXX | XXX | XXX |
| EBIT Margin | XXX | 0% | XXX | XXX | XXX |
| Net Profit | XXX | -$26.4M | XXX | XXX | XXX |
| Net Margin | XXX | -2% | XXX | XXX | XXX |
| Net Debt | XXX | $226M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, ShuYu Civilian Pharmacy's stock price is CNY 13 (or $2).
ShuYu Civilian Pharmacy has current market cap of CNY 5.2B (or $720M), and EV of CNY 7.7B (or $1.1B).
See ShuYu Civilian Pharmacy trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $720M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, ShuYu Civilian Pharmacy has market cap of $720M and EV of $1.1B.
ShuYu Civilian Pharmacy's trades at 0.8x EV/Revenue multiple, and 18.8x EV/EBITDA.
Equity research analysts estimate ShuYu Civilian Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
ShuYu Civilian Pharmacy's P/E ratio is not available.
See valuation multiples for ShuYu Civilian Pharmacy and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $720M | XXX | $720M | XXX | XXX | XXX |
| EV (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 18.8x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 312.1x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -27.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 24.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialShuYu Civilian Pharmacy's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
ShuYu Civilian Pharmacy's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
ShuYu Civilian Pharmacy's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for ShuYu Civilian Pharmacy and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ShuYu Civilian Pharmacy acquired XXX companies to date.
Last acquisition by ShuYu Civilian Pharmacy was XXXXXXXX, XXXXX XXXXX XXXXXX . ShuYu Civilian Pharmacy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was ShuYu Civilian Pharmacy founded? | ShuYu Civilian Pharmacy was founded in 1999. |
| Where is ShuYu Civilian Pharmacy headquartered? | ShuYu Civilian Pharmacy is headquartered in China. |
| Is ShuYu Civilian Pharmacy publicy listed? | Yes, ShuYu Civilian Pharmacy is a public company listed on SHE. |
| What is the stock symbol of ShuYu Civilian Pharmacy? | ShuYu Civilian Pharmacy trades under 301017 ticker. |
| When did ShuYu Civilian Pharmacy go public? | ShuYu Civilian Pharmacy went public in 2021. |
| Who are competitors of ShuYu Civilian Pharmacy? | Similar companies to ShuYu Civilian Pharmacy include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of ShuYu Civilian Pharmacy? | ShuYu Civilian Pharmacy's current market cap is $720M |
| Is ShuYu Civilian Pharmacy profitable? | Yes, ShuYu Civilian Pharmacy is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
